Phase 2 RCT | Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes
30 Mar, 2023 | 14:08h | UTCSafety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)